U.S. markets open in 8 hours 27 minutes
  • S&P Futures

    4,271.50
    -9.50 (-0.22%)
     
  • Dow Futures

    33,647.00
    -71.00 (-0.21%)
     
  • Nasdaq Futures

    13,544.00
    -33.75 (-0.25%)
     
  • Russell 2000 Futures

    2,011.00
    -5.90 (-0.29%)
     
  • Crude Oil

    91.19
    -0.90 (-0.98%)
     
  • Gold

    1,809.40
    -6.10 (-0.34%)
     
  • Silver

    20.61
    -0.08 (-0.40%)
     
  • EUR/USD

    1.0253
    -0.0004 (-0.04%)
     
  • 10-Yr Bond

    2.8490
    0.0000 (0.00%)
     
  • Vix

    19.53
    -0.67 (-3.32%)
     
  • GBP/USD

    1.2118
    -0.0021 (-0.17%)
     
  • USD/JPY

    133.2180
    -0.2620 (-0.20%)
     
  • BTC-USD

    24,847.09
    +276.91 (+1.13%)
     
  • CMC Crypto 200

    592.18
    +20.90 (+3.66%)
     
  • FTSE 100

    7,500.89
    +34.98 (+0.47%)
     
  • Nikkei 225

    28,884.84
    +337.86 (+1.18%)
     

Vancouver biotech announces machine-learning 'breakthrough'

·2 min read
Vancouver biotech announces machine-learning 'breakthrough'
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Absci Corp. (Nasdaq: ABSI) announced Tuesday what the synthetic biology company is calling a breakthrough in machine-learning for designing novel therapeutic antibodies. Absci said the announcement marks a big step forward in its progress toward a fully computer-based machine learning pipeline for protein-based drug discovery, going from target to drug candidate sequence with the "click of a button." CEO Sean McClain said Absci is looking to publish its findings in a peer-reviewed journal.